Anavex Life Sciences Receivables

Anavex Life Sciences (0HFR.L) currently reports a receivables of $1M as of June 2026. That compares with $820K in the prior-year period — up 21.3% year over year. Use the charts on this page to explore Anavex Life Sciences's receivables history and peer comparisons.

Anavex Life Sciences's receivables increased from $820K to $1M — a 21.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Anavex Life Sciences reported $1M in receivables as of June 2026. That compares with $820K in the prior-year period — up 21.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anavex Life Sciences, and consider following 0HFR.L for alerts when major investors trade the stock.

Anavex Life Sciences is classified in the Healthcare sector. On receivables, it currently shows $1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 0HFR.L with unrelated industries.